news
Ultrathin endoscope captures neurons firing deep in the brain
A new fibre-based endoscope, tested in mice, poised to bring new insights into brain function...
List view / Grid view
Dementia
news
Nicotinic receptor research paves way for targeted dementia therapy
A new study which identifies how acetylcholine impacts learning and memory by acting at different receptors could prove significant in the drive to develop more targeted and effective therapies for dementia...
news
Gut bacteria linked to age-related conditions
Study suggests that chronic inflammation in the elderly -- thought to be involved in many age-related diseases -- is due to imbalances in gut bacteria...
news
Two new genes linked to Alzheimer’s risk
Researchers have identified two genes that influence a person’s risk of developing Alzheimer’s disease.
news
MESO-BRAIN initiative receives €3.3 million in funding
9 June 2016 | By Victoria White, Digital Content Producer
The Meso-Brain project could revolutionise the understanding of disease and lead to new treatments for those with dementia or brain injuries...
news
New set of genes associated with stroke identified
8 April 2016 | By Victoria White, Digital Content Producer
Researchers identified a new gene called FOXF2 which increased the risk of having a stroke due to small vessel disease in the brain...
news
AbbVie announced as the latest Dementia Consortium partner
16 February 2016 | By Victoria White
AbbVie has been announced as the latest Dementia Consortium partner, joining MRC Technology, Alzheimer’s Research UK, Astex, Eisai and Lilly...
news
Neurodegenerative diseases: The potential of cyclophilin inhibition
21 January 2016 | By Hans Fliri PhD, Chairman, Cypralis
Here, Dr Hans Fliri, Chairman and CEO of Selcia and Chairman of Cypralis, presents a strong case for targeting mitochondrial cyclophilin D to prevent progression of chronic neurodegenerative diseases...
news
First clinical trial for vaccine targeting Alzheimer’s in people with Down’s syndrome
7 January 2016 | By Nicholas Jackson
Plans for the world’s first clinical trial for a vaccine targeting Alzheimer’s disease-like characteristics in those with Down's syndrome have been announced...
news
Memory drug BPN14770 moves into Phase 1 safety trial
4 January 2016 | By Victoria White
BPN14770 may be a possible treatment for dementia and Alzheimer’s disease with less potential for side effects than rolipram...
news
Enhancing proteasome activity may prevent dementia
22 December 2015 | By Victoria White
A study suggests that enhancing proteasome activity with drugs during the early stages of Alzheimer’s may prevent dementia and reduce damage to the brain...
news
Scientists use light to treat Alzheimer’s disease
16 November 2015 | By Victoria White
Scientists have conducted research to suppress an abnormal assembly of beta-amyloids by using photo-excited porphyrins...
news
Experimental Alzheimer’s drug J147 shows anti-aging effects
13 November 2015 | By Victoria White
Mice treated with J147 had better memory and cognition, healthier blood vessels in the brain and other improved physiological features...
news
RNA-binding proteins play important role in motor neurone disease
30 October 2015 | By Victoria White
The discovery about the FUS protein could be a major milestone on the path to a treatment for both motor neurone disease and dementia...
news
Launch of Dementia Discovery Fund to deliver new dementia treatments by 2025
21 October 2015 | By Kate Douetil
This innovative new global investment fund has gained support from a wide variety of investors, including the UK Government’s Department of Health (DoH), Alzheimer’s Research UK and world-leading major pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda...